NHS approves new non-hormonal menopause drug to treat hot flushes
A groundbreaking non hormonal medication for menopausal symptoms has been given the green light for NHS use in England today. The National Institute for Health and Care Excellence approved Veoza, also known as fezolinetant, on Wednesday, opening up a much needed treatment pathway for women struggling with hot flushes and night sweats. It s promising news for the estimated 500 000 women across England who can t take hormone replacement therapy for various medical reasons. The drug, manufactured
A groundbreaking non hormonal medication for menopausal symptoms has been given the green light for NHS use in England today. The National Institute for Health and Care Excellence approved Veoza, also known as fezolinetant, on Wednesday, opening up a much needed treatment pathway for women struggling with hot flushes and night sweats. It s promising news for the estimated 500 000 women across England who can t take hormone replacement therapy for various medical reasons. The drug, manufactured
Tags
Related Posts
Meta AI head on ‘disappointing’ AI model claims, 'we’ve been upfront'
Meta s new AI model, Muse Spark, powering its AI assistant, has drawn criticism for prioritizing benchmarks over real world utility. While Meta acknowledges performance gaps, it highlights user satisfaction in areas like visual coding and reasoning. This initial model, designed for speed and capability, is set to power Meta s platforms soon
IPL 2026: Shubman Gill punished despite GT’s last-ball thriller win over DC
Shubman Gill s Gujarat Titans clinched a thrilling one run victory against Delhi Capitals in IPL 2026. Despite the dramatic win, Gill was fined Rs 12 lakh for a slow over rate, marking the team s first offense. The captain s tactical decisions, including a crucial gamble on the final ball, ultimately secured the hard fought win
'Dhurandhar 2' box office collection Day 21: Ranveer Singh starrer dips under Rs 10 crore
Aditya Dhar s 'Dhurandhar 2: The Revenge' continues its record breaking spree, crossing Rs 1 000 crore net in India and achieving a worldwide gross of Rs 1 653. Despite a slight dip on its 21st day, the film has secured a spot in the top 10 highest grossing films globally for 2026, marking a significant international triumph for Indian cinema